- Published on
Ophthalmology – Albinism
Albinism refers to a group of inherited disorders characterized by reduced or absent melanin production due to defects in melanin synthesis or melanosome formation. It is broadly classified into oculocutaneous albinism (OCA), which affects the skin, hair, and eyes, and ocular albinism (OA), which primarily involves the eyes. OCA includes several subtypes (OCA1–OCA4), each caused by different genetic mutations but often showing overlapping clinical features. OCA1 typically presents with white hair, pale skin, and light irides, while OCA2 tends to be milder and is more common in African and certain Native American populations. OCA3 presents with brown or reddish pigmentation and is more frequent in African populations, whereas OCA4 resembles OCA2 and is more common in parts of Asia. Ocular albinism, most commonly the Nettleship-Falls type, is usually X-linked and primarily affects males, with females often being carriers.
The condition occurs worldwide with an incidence of approximately 1 in 20,000 births, and about 1 in 17,000 individuals are affected by some form of albinism. Genetic inheritance for OCA is usually autosomal recessive, involving mutations in genes such as TYR, OCA2, TYRP1, and SLC45A2, while OA is typically X-linked recessive involving the GPR143 gene. The pathophysiology involves hypopigmentation of the retinal pigment epithelium during development, leading to abnormal foveal formation (macular hypoplasia), delayed retinal ganglion cell development, and misrouting of optic nerve fibers at the optic chiasm.
Clinically, patients present with a range of ocular findings including congenital nystagmus, strabismus, reduced visual acuity (typically between 20/40 and 20/400), refractive errors, amblyopia, iris transillumination, photophobia, and hypopigmented fundus with visible choroidal vasculature. Macular hypoplasia is a key feature contributing to reduced vision. Optic nerves may appear gray and may show hypoplasia. Cutaneous features in OCA include hypopigmented skin and hair, with some individuals developing freckles or nevi. A detailed history should include family history, visual symptoms, photosensitivity, and systemic features such as easy bruising or recurrent infections, which may suggest associated syndromes.
Albinism can be associated with systemic conditions such as Hermansky–Pudlak syndrome, which includes platelet dysfunction and risk of bleeding as well as pulmonary and gastrointestinal complications; Chediak–Higashi syndrome, which involves immune deficiency and recurrent infections; and Griscelli syndrome, which may include neurological or immunological abnormalities. It may also be seen in syndromes such as Prader-Willi and Angelman syndromes.
Diagnosis is primarily clinical but may be supported by genetic testing to identify specific mutations. Optical coherence tomography demonstrates macular hypoplasia, and visual evoked potential testing reveals abnormal decussation of optic nerve fibers. Skin biopsy in certain forms may show characteristic macromelanosomes. Prenatal diagnosis is possible if the genetic mutation is known.
Management is supportive and aimed at optimizing vision and protecting the skin. Refractive errors should be corrected with glasses or contact lenses, and amblyopia should be treated when present. Tinted lenses can help reduce photophobia, and low vision aids such as magnifiers and high-contrast reading materials can improve functional vision. Sun protection is essential, including the use of sunscreen and protective clothing, due to the increased risk of skin damage and malignancy.
Patients require regular follow-up with ophthalmology, low vision services, and dermatology for skin monitoring. Hematology evaluation may be necessary if syndromic associations are suspected. The overall prognosis is generally good in terms of lifespan, development, and fertility, although visual acuity remains reduced and patients are at increased risk for skin cancers such as basal cell carcinoma, squamous cell carcinoma, and actinic keratosis.
Albinism refers to a group of inherited disorders characterized by reduced or absent melanin production due to defects in melanin synthesis or melanosome formation. It is broadly classified into oculocutaneous albinism (OCA), which affects the skin, hair, and eyes, and ocular albinism (OA), which primarily involves the eyes. OCA includes several subtypes (OCA1–OCA4), each caused by different genetic mutations but often showing overlapping clinical features. OCA1 typically presents with white hair, pale skin, and light irides, while OCA2 tends to be milder and is more common in African and certain Native American populations. OCA3 presents with brown or reddish pigmentation and is more frequent in African populations, whereas OCA4 resembles OCA2 and is more common in parts of Asia. Ocular albinism, most commonly the Nettleship-Falls type, is usually X-linked and primarily affects males, with females often being carriers.
The condition occurs worldwide with an incidence of approximately 1 in 20,000 births, and about 1 in 17,000 individuals are affected by some form of albinism. Genetic inheritance for OCA is usually autosomal recessive, involving mutations in genes such as TYR, OCA2, TYRP1, and SLC45A2, while OA is typically X-linked recessive involving the GPR143 gene. The pathophysiology involves hypopigmentation of the retinal pigment epithelium during development, leading to abnormal foveal formation (macular hypoplasia), delayed retinal ganglion cell development, and misrouting of optic nerve fibers at the optic chiasm.
Clinically, patients present with a range of ocular findings including congenital nystagmus, strabismus, reduced visual acuity (typically between 20/40 and 20/400), refractive errors, amblyopia, iris transillumination, photophobia, and hypopigmented fundus with visible choroidal vasculature. Macular hypoplasia is a key feature contributing to reduced vision. Optic nerves may appear gray and may show hypoplasia. Cutaneous features in OCA include hypopigmented skin and hair, with some individuals developing freckles or nevi. A detailed history should include family history, visual symptoms, photosensitivity, and systemic features such as easy bruising or recurrent infections, which may suggest associated syndromes.
Albinism can be associated with systemic conditions such as Hermansky–Pudlak syndrome, which includes platelet dysfunction and risk of bleeding as well as pulmonary and gastrointestinal complications; Chediak–Higashi syndrome, which involves immune deficiency and recurrent infections; and Griscelli syndrome, which may include neurological or immunological abnormalities. It may also be seen in syndromes such as Prader-Willi and Angelman syndromes.
Diagnosis is primarily clinical but may be supported by genetic testing to identify specific mutations. Optical coherence tomography demonstrates macular hypoplasia, and visual evoked potential testing reveals abnormal decussation of optic nerve fibers. Skin biopsy in certain forms may show characteristic macromelanosomes. Prenatal diagnosis is possible if the genetic mutation is known.
Management is supportive and aimed at optimizing vision and protecting the skin. Refractive errors should be corrected with glasses or contact lenses, and amblyopia should be treated when present. Tinted lenses can help reduce photophobia, and low vision aids such as magnifiers and high-contrast reading materials can improve functional vision. Sun protection is essential, including the use of sunscreen and protective clothing, due to the increased risk of skin damage and malignancy.
Patients require regular follow-up with ophthalmology, low vision services, and dermatology for skin monitoring. Hematology evaluation may be necessary if syndromic associations are suspected. The overall prognosis is generally good in terms of lifespan, development, and fertility, although visual acuity remains reduced and patients are at increased risk for skin cancers such as basal cell carcinoma, squamous cell carcinoma, and actinic keratosis.
0 Comments
